Catalyst Wire Dossier Catalyst Wire Dossier

Pfs25 VLP-FhCMB malaria transmission-blocking vaccine

· Fraunhofer Center for Molecular Biotechnology
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Pfs25 VLP-FhCMB malaria transmission-blocking vaccine, covering 2017-01-18 to 2017-01-18. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Immunogenicity of Plant-Derived Pfs25 VLP-FhCMB Malaria Transmission Blocking Vaccine in Healthy Adults [Phase 1]

See pricing